Transparency at Bristol-Myers Squibb
We believe in providing an open environment to help build a foundation of trust and respect among our colleagues, health care professionals, patients, stockholders and the public. We operate our business with high standards of business integrity and ethics; complying with the letter and spirit of current laws and regulations. We strongly believe in the importance of making information about our medicines available as we continue to seek a better understanding of the needs of our patients and customers. We are committed to disclosing information about our business in the following areas:
As a company, we are dedicated to educating our patients, medical/research communities, the media, policy makers and the general public. We believe in the integrity of the information we collect and are committed to communicating our data.
We address areas of community and unmet medical need through a variety of grant-making programs, each with its own focus. We are committed to making information about our giving and grant-making available to the public.
We support the Physician Payments Sunshine Act as an extension of our own efforts to increase public awareness of the positive role that physician-industry collaboration plays in helping patients prevail over serious diseases.
As active participants in providing health care access to patients, we engage in government advocacy to ensure that we foster continued innovation and we contribute to the state and local candidates and political organizations that support our views on health care issues affecting the industry, when permitted by law. Information about our political activities and contributions is available.
We conduct our business to help patients prevail over serious diseases in a manner that contributes to economic growth, social responsibility and a healthy environment now and in the future. Our Company progress is available, along with other important information.